$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Why is Kroger closing stores nationwide? How will US chip export limits impact global tech? What drives Toyota’s planned US price hike? How does Tesla’s robotaxi launch affect its stock? Why is Meta offering massive AI signing bonuses? What explains the recent surge in oil prices? How is the Israel-Iran conflict affecting markets?

$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

benzinga.com/insights/news/25/06/46039116/100-invested-in-regeneron-pharmaceuticals-20-years-ago-would-be-worth-this-much-today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.22% on an annualized basis producing an average annual return of 22.54%. Currently, Regeneron Pharmaceuticals has a market capitalization of $55.03 billion.
Buying $100 In REGN: If ...
Full…

This story appeared on benzinga.com, 2025-06-20 21:00:19.